Content Type: Article

  • Foreign Investment in India: What Foreign Investors Need to Know

    Foreign Investment in India: What Foreign Investors Need to Know

    ARTICLE / CLIENT ALERT

    Foreign Investment in India: What Foreign Investors Need to Know

    March 5, 2021

    Read time: 4 min

    Key takeaways
    Overview

    India, one of the world’s largest economies, remains an attractive market for foreign direct investment (FDI). Since 1991, the Indian FDI legal and regulatory framework has seen continuous reforms. Foreign investors can invest in most sectors of the Indian economy without the Government of India’s (GOI) prior approval. The two channels are commonly referred to as the “automatic route” and the “approval route.” However it is important to note that certain sectors are entirely prohibited from accepting FDI, and certain sectors under the approval and the automatic routes are subject to FDI caps.

    In depth

    Press Note 3: Restricted Countries / Restricted Persons

    On April 18, 2020, India amended its FDI policy through a new “press note” (Press Note 3) which announced the requirement of the GOI’s prior approval (i.e., the approval route) for any FDI inbound from countries that share a land border with India, irrespective of the sector. This has implications for Afghanistan, Bangladesh, Bhutan, China, Myanmar, Nepal, and Pakistan (all bordering India, viz, the Restricted Countries).

    The official remit of Press Note 3 is to curb “opportunistic takeovers/acquisitions” of Indian companies in the wake of COVID-19. However, the practical effect of Press Note 3 is much broader. Essentially, prior GOI approval for FDI into India is required if:

    1. the investor entity is from a Restricted Country, or the beneficial owner of the investor entity is based in, or is a citizen of, a Restricted Country;
    2. any direct or indirect changes in the beneficial ownership of any existing or future FDI would result in such beneficial ownership falling into the hands of persons referred to in (i) above. (for convenience, persons referred to in (i) and (ii) are being referred to as Restricted Persons).

    Implications for FDI into India

    Press Note 3 targets new or follow-on FDI, or changes to the existing FDI involving China, a circumstance of particular note as China has become one of the largest FDI providers in India.

    Press Note 3 also covers those foreign investors whose beneficial owners are Restricted Persons or where interest in any Indian entity is directly or indirectly transferred to a Restricted Person.

    The GOI is yet to provide guidance as to how (i) it will evaluate and approve the FDI proposals (ii) it will define and calculate the beneficial ownership under Press Note 3.

    A key issue is that there is no de minimis/materiality threshold for the beneficial ownership or clarity of the meaning of the term “beneficial ownership.” As Chinese investors have invested in several international entities, including PE and VC funds, technically FDI into India from such international entities (including any minority stake) is also covered by Press Note 3 requiring prior GOI approval under the approval route.

    Some banks processing FDI into India (referred to as “Authorised Dealers”) are taking different views on the de minimis / materiality threshold (ranging from 10% to 25%) for the beneficial ownership if the FDI into India is from international entities, i.e., Authorised Dealers applying Press Note 3 and requiring prior GOI approval if the Restricted Persons own more 10% / 25% in the international entity.

    Conclusion

    Press Note 3 is expected to have an adverse effect on new or follow-on FDI from China. It is important to note that Press Note 3 does not affect existing investments from China. However, Press Note 3 applies if any changes are made to existing Chinese FDI after April 18, 2020, i.e., the date of Press Note 3. Press Note 3 will also affect investors from non-Restricted Countries if such investors have direct or indirect beneficial owners situated in, or are citizens of, Restricted Countries.

    While the recent steps taken by the GOI to welcome and increase FDI into India has increased investor confidence, Press Note 3 has unfortunately raised unintended issues given that casting this “wide net” results in “indirect beneficial owners” being caught as well. Further clarity from the GOI is expected in relation to the application and interpretation of Press Note 3, which will help clarify the position on FDI for market participants.

    Authors
    More insights

  • Federal COVID-19 Relief Law Could Prevent New State Tax Incentives

    Federal COVID-19 Relief Law Could Prevent New State Tax Incentives

    ARTICLE

    Federal COVID-19 Relief Law Could Prevent New State Tax Incentives

    March 5, 2021

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Lowell D. Yoder

    Partner

    Chicago

    More insights

  • SEC Examinations Update: 2021 Examination Priorities

    SEC Examinations Update: 2021 Examination Priorities

    ARTICLE / CLIENT ALERT

    SEC Examinations Update: 2021 Examination Priorities

    March 4, 2021

    Read time: 10 min

    Key takeaways
    Overview

    On March 3, 2021, the SEC’s Division of Examinations released its 2021 Examination Priorities (“Exam Priorities”). While the Exam Priorities address the Division of Examinations’ focus for all of the SEC’s registrants, certain focus areas will be of particular interest to private fund managers. Consistent with what we have seen during examinations over the last 12 to 18 months, those focus areas include conflicts of interest, compliance programs, ESG and climate change, digital assets, alternative data and structured products.

    • Compliance Programs. Not unexpectedly, the Division of Examinations will continue its focus on the overall strength of investment adviser’s compliance programs, to confirm that “policies and procedures are reasonably designed, implemented, and maintained.” Of particular relevance to private fund managers, the examination staff identified the following areas for assessment, “portfolio management practices, custody and safekeeping of client assets, best execution, fees and expenses, business continuity plans, and valuation of client assets for consistency and appropriateness of methodology.” This reinforces the SEC staff’s focus on ensuring that investment advisers understand and effect their core responsibilities under the Compliance Rule (Rule 206(4)-7), particularly following the Division of Examination’s November 2020 Risk Alert, which identified these same areas as being common sources of examination deficiencies.
    • “Knowledgeable and Empowered CCOs.” The Exam Priorities reiterated the recent statements of the Examinations Director Peter Driscoll about critical attributes of a chief compliance officer: knowledge, seniority, authority, resources and tangible support from the C-suite and all levels of the organization.
    • ESG and Climate Disclosure. While regulators in other jurisdictions have been active in promulgating rules related to the incorporation of ESG criteria by investment advisers into their research and investment process (and any related disclosures, including climate-related disclosures), the SEC had taken a different approach. The recognition in the Exam Priorities that investment advisers “are increasingly offering investment strategies that focus on sustainability” and statements that the examination staff will “review the consistency and adequacy of the disclosures [investment advisers] … provide to clients regarding these strategies, determine whether the firms’ processes and practices match their disclosures, review fund advertising for false or misleading statements, and review proxy voting policies and procedures and votes to assess whether they align with [ESG] strategies” suggests a shift towards a more proactive approach among the staff of the Division of Examinations. This is a marked change, given that Division made only one reference to ESG in its 2020 Examination Priorities.
    • Digital Assets. The Division of Examinations had made its focus on digital assets known just a few days ago, in a Risk Alert identifying recent examination deficiencies related to digital assets, and their likely focus of examinations going forward. Their inclusion in the Exam Priorities reiterates that attention. The digital asset risk alert identified the following as areas of focus for examinations going forward: diligence on digital assets; alignment of investment adviser regarding digital assets with an adviser’s fiduciary duty; maintaining appropriate books and records; custody and safekeeping; disclosure related to the “technical, legal, market, and operational risks” of digital assets; and valuation methodologies. The Exam Priorities largely reflect those themes with respect to examinations of investment advisers, and include a review of any digital assets specific policies and procedures as well.
    • Structured Products and Non-Performing Loans. In a section dedicated to examinations of private fund managers, the Exam Priorities primarily discussed two topics, conflicts of interest (described below) and funds that hold a higher concentration of structured products, such as CLOs and mortgage-backed securities. Particularly, the examination staff will seek to determine whether funds that hold these investments are at a “higher risk for holding non-performing loans and having loans with higher default risk than that disclosed to investors.” We have observed that the Division of Examinations has shown increased willingness to conduct examinations of managers who employ these strategies as members of the examination staff have become increasingly sophisticated with respect to these products and work with their colleagues in other SEC divisions who have expertise with complex financial instruments.
    • Conflicts of Interest. Since the SEC issued the Commission Interpretation Regarding Standard of Conduct for Investment Advisers (“Fiduciary Interpretation”), which, among other things, provided guidance with respect to how investment advisers can address conflicts of interest in light of their fiduciary duty, there has been increased examination focus on conflicts of interest (although the level of focus was already significant). In the Exam Priorities, the Division of Examinations indicated that will continue, with a particular focus on preferential treatment of investors in light of liquidity constraints; the impact of valuations on advisory fees; adequacy of disclosures with respect to cross trades, principal investments or distressed sales; and conflicts surrounding fund restructurings led by investment advisers. Examiners, particularly examiners in the Division’s Private Funds Unit, can spend substantial time addressing these topics during examinations.
    • Alternative Data. Examination staff have been reviewing the use of alternative data by registered advisers throughout the past year and the Exam Priorities indicates this focus will continue. The focus will include “whether firms are implementing appropriate controls and compliance around the creation, receipt, and use of such information.”

    With respect to private fund managers, the Exam Priorities reflect certain long-standing (compliance programs, conflicts of interest) and certain relatively new (ESG, digital assets, structured products) areas of focus. As the SEC moves into an era with new leadership, these focus areas can be expected to develop further.

    Authored by Brian T. Daly, Marc E. Elovitz  Craig S. Warkol, Kelly Koscuiszka, Christopher S. Avellaneda and Tarik M. Shah.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Marc E. Elovitz

    Partner

    New York – 919 Third Avenue

    Kelly Koscuiszka

    Partner

    New York – 919 Third Avenue

    Christopher S. Avellaneda

    Partner

    New York – 919 Third Avenue

    Tarik M. Shah

    Partner

    New York – 919 Third Avenue

    More insights

  • DOL Issues Clarification for ERISA-Governed Group Health Plans

    DOL Issues Clarification for ERISA-Governed Group Health Plans

    ARTICLE / CLIENT ALERT

    DOL Issues Clarification for ERISA-Governed Group Health Plans

    March 3, 2021

    Read time: 3 min

    Key takeaways
    Overview

    Two days before the one-year anniversary of the official start of the COVID-19 outbreak, the US Department of Labor (DOL) issued a last-minute notice clarifying its prior guidance that relaxed the deadlines for the Employee Retirement Income Security Act -governed group health and welfare plans (ERISA) related to the Consolidated Omnibus Budget Reconciliation Act (COBRA) and various special enrollment and claims procedures. Employee Benefits Security Administration (EBSA) Disaster Relief Notice 2021-01 (Notice 2021-01) advises that for the deadlines subject to relief under the prior guidance, plans should continue to disregard the outbreak period in calculating timing requirements until the earlier of:

    • One year from the date an individual (emphasis added) was first eligible for relief (March 1, 2020, the first day of the outbreak period, being the first date an individual could be eligible), or
    • 60 days from the announced end of the outbreak period

    And, under no circumstances will the disregarded period for any given individual exceed one year. The guidance effectively “tolls” the deadlines on an individualized basis. For example, if a qualified beneficiary would have been required to make a COBRA election by March 1, 2021, that individual has either until the earlier of March 1, 2022, (one year from the date they were first eligible) or the end of the outbreak period—if that is announced before March 1, 2022.

    Notice 2021-01 also suggests plan sponsors send communications to participants whose deadlines are quickly approaching. Plans might want to reissue any pre-pandemic communications sent out that do not accurately reflect the new deadlines to participants. This may help to mitigate the risk of suits by participants for incorrect deadlines.

    In conclusion, though Notice 2021-01 provided a needed answer, it clarifies little by imposing unique, individual-specific deadlines. Organizations like the American Benefits Council had advocated setting a clear end to the outbreak period on February 28, 2021, but it became apparent in recent months as the pandemic persisted that it was uncertain how the DOL and US Department of the Treasury would handle setting the one-year limit. This decision, unfortunately, will no doubt lead to confusion among plan sponsors and service providers and increased administrative burdens. Plans should continue to watch for more guidance on this issue.

    In depth
    Authors

    Jacob M. Mattinson

    Partner

    Chicago

    More insights

  • Rapid Antigen Tests – Compulsory Testing at the Workplace?

    Rapid Antigen Tests – Compulsory Testing at the Workplace?

    ARTICLE / CLIENT ALERT

    Rapid Antigen Tests – Compulsory Testing at the Workplace?

    March, 3, 2021

    Read time: 2 min

    Key takeaways
    Overview

    The first rapid antigen tests have been approved for self-testing. There are now also much more convenient alternatives to the nasopharyngeal swab (“spit test”/”nasal test”). Companies could now use these tests to “entrance cotrol” their employees to protect sensitive areas of the company that require on-site presence. Our assessment of the use of such tests can be found on our blog.

    In depth
    Authors

    Dr. Thomas Gennert

    Partner

    Düsseldorf

    More insights

  • Healthcare M&A Predictions, Take Two: Under Biden & Post-COVID-19

    Healthcare M&A Predictions, Take Two: Under Biden & Post-COVID-19

    ARTICLE

    Healthcare M&A Predictions, Take Two: Under Biden & Post-COVID-19

    March 3, 2021

    Read time: 1 min

    Key takeaways
    Overview

     

     

    In depth
    Authors

    Kerrin B. Slattery

    Partner

    Chicago

    More insights

  • Wills, Trusts and Tax Planning for Adjudicated Disabled Persons and Minors

    Wills, Trusts and Tax Planning for Adjudicated Disabled Persons and Minors

    ARTICLE

    Wills, Trusts and Tax Planning for Adjudicated Disabled Persons and Minors

    March 1, 2021

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    David A. Baker

    Partner

    Chicago

    More insights

  • Intelligently Evolving Your Corporate Compliance Program

    Intelligently Evolving Your Corporate Compliance Program

    ARTICLE

    Intelligently Evolving Your Corporate Compliance Program

    March 1, 2021

    Read time: 1 min

    Key takeaways
    Overview
    In depth
    Authors

    Martha K. Louks

    Director of Technology Services

    Washington, DC

    More insights

  • 2021: The Year ESG Goes Mainstream

    2021: The Year ESG Goes Mainstream

    ARTICLE

    2021: The Year ESG Goes Mainstream

    February 2021

    Read time: 1 min

    Key takeaways
    Overview

     

     

    In depth
    Authors

    Thomas M. Dawson

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • Key Takeaways and Q&A | Return to Work Virtual Toolkit for Employers | The COVID-19 Vaccine: What Can Employers Require?

    Key Takeaways and Q&A | Return to Work Virtual Toolkit for Employers | The COVID-19 Vaccine: What Can Employers Require?

    ARTICLE

    Key Takeaways and Q&A | Return to Work Virtual Toolkit for Employers | The COVID-19 Vaccine: What Can Employers Require?

    February 25, 2021

    Read time: 2 min

    Key takeaways
    Overview

    The COVID-19 pandemic has put unprecedented strain on organizations of all sizes across all industries. The uncertainty of the “new normal” is forcing employers all over the world to consider various new policies as workers return to the workplace. To properly navigate the complexities of these novel COVID-19 employment issues, you need innovative but practical solutions.

    With the COVID-19 vaccination process underway, employers are navigating unprecedented issues within their workforce. Our webinar explored the most pressing questions employers are asking—including whether employers can (and should) mandate the vaccine—as well as other novel workplace challenges stemming from the rollout of the vaccine.

    View the full webinar here.

    In depth
    Authors
    More insights